Cargando…

Uric Acid Lowering and Biomarkers of Kidney Damage in CKD Stage 3: A Post Hoc Analysis of a Randomized Clinical Trial

RATIONALE & OBJECTIVE: Hyperuricemia is associated with chronic kidney disease (CKD) progression. We evaluated whether lowering serum uric acid levels improves levels of biomarkers of kidney damage. STUDY DESIGN: Post hoc analysis of clinical trial participants. SETTING & PARTICIPANTS: A dou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Perrenoud, Loni, Kruse, Nicholas T., Andrews, Emily, You, Zhiying, Chonchol, Michel, Wu, Chaorong, Ten Eyck, Patrick, Zepeda-Orozco, Diana, Jalal, Diana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7487946/ https://www.ncbi.nlm.nih.gov/pubmed/32964203 http://dx.doi.org/10.1016/j.xkme.2019.11.007

Ejemplares similares

Examining the effects of uric acid-lowering on markers vascular of calcification and CKD-MBD; A post-hoc analysis of a randomized clinical trial
por: Andrews, Emily S., et al.
Publicado: (2018)

Allopurinol Lowers Serum Urate but Does Not Reduce Oxidative Stress in CKD
por: Sun, Mingyao, et al.
Publicado: (2022)

Evaluating the feasibility of a pharmacist-guided patient-driven intervention to improve blood pressure control in patients with CKD
por: Hopley, Charles, et al.
Publicado: (2019)

Vascular Endothelial Function Is Not Related to Serum Uric Acid in Healthy Adults
por: Jalal, Diana I., et al.
Publicado: (2012)

Detection of pro angiogenic and inflammatory biomarkers in patients with CKD
por: Jalal, Diana, et al.
Publicado: (2021)

Uric acid lowering for slowing CKD progression after the CKD-FIX trial: a solved question or still a dilemma?
por: Leoncini, Giovanna, et al.
Publicado: (2022)

Serum uric acid and the incidence of CKD and hypertension
por: Kuriyama, Satoru, et al.
Publicado: (2015)

Mitochondrial Oxidative Metabolism: An Emerging Therapeutic Target to Improve CKD Outcomes
por: Mapuskar, Kranti A., et al.
Publicado: (2023)

The effect of dapagliflozin on uric acid excretion and serum uric acid level in advanced CKD
por: Iwata, Yukimasa, et al.
Publicado: (2023)

Characterization of Primary Cilia in Osteoblasts Isolated From Patients With ADPKD and CKD
por: Pereira, Renata C, et al.
Publicado: (2021)

Endothelial Microparticles and Systemic Complement Activation in Patients With Chronic Kidney Disease
por: Jalal, Diana, et al.
Publicado: (2018)

Effects of Uric Acid on Lipid Levels in CKD Patients in a Randomized Controlled Trial
por: Bowden, Rodney G., et al.
Publicado: (2013)

Uric Acid and Prevalence of Hypertension in a General Population of Japanese: ISSA-CKD Study
por: Miyabayashi, Ikuko, et al.
Publicado: (2020)

Association of Plant-Based Protein Intake with Cognitive Function in Adults with CKD
por: Perez, Luis, et al.
Publicado: (2023)

Pain and Obesity in Autosomal Dominant Polycystic Kidney Disease: A Post Hoc Analysis of the Halt Progression of Polycystic Kidney Disease (HALT-PKD) Studies
por: Nowak, Kristen L., et al.
Publicado: (2021)

Affected parent sex and severity of autosomal dominant polycystic kidney disease: a retrospective cohort study
por: Nowak, Kristen L., et al.
Publicado: (2018)

Finerenone in Hispanic Patients With CKD and Type 2 Diabetes: A Post Hoc FIDELITY Analysis
por: Rosas, Sylvia E., et al.
Publicado: (2023)

Use of Glucose-Lowering Agents in Diabetes and CKD
por: Alicic, Radica Z., et al.
Publicado: (2022)

Serum Uric Acid Levels and Incident Chronic Kidney Disease in Patients With Type 2 Diabetes and Preserved Kidney Function
por: Zoppini, Giacomo, et al.
Publicado: (2012)

Acute Kidney Injury Is Associated With an Increased Risk of Dementia
por: Kendrick, Jessica, et al.
Publicado: (2019)

Inspiratory muscle strength training for lowering blood pressure and improving endothelial function in postmenopausal women: comparison with “standard of care” aerobic exercise
por: Craighead, Daniel H., et al.
Publicado: (2022)

Impaired Renal Function Further Increases Odds of 6-Year Coronary Artery Calcification Progression in Adults With Type 1 Diabetes: The CACTI study
por: Maahs, David M., et al.
Publicado: (2013)

Dialysis disequilibrium syndrome
por: Zepeda-Orozco, Diana, et al.
Publicado: (2012)

Lower serum calcium is independently associated with CKD progression
por: Janmaat, Cynthia J., et al.
Publicado: (2018)

Optimized Detection of Acute MHV68 Infection With a Reporter System Identifies Large Peritoneal Macrophages as a Dominant Target of Primary Infection
por: Riggs, Julianne B., et al.
Publicado: (2021)

Empagliflozin and uric acid metabolism in diabetes: A post hoc analysis of the EMPA‐REG OUTCOME trial
por: Ferreira, João Pedro, et al.
Publicado: (2021)

Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
por: Ying, Hangying, et al.
Publicado: (2021)

Curcumin therapy to treat vascular dysfunction in children and young adults with autosomal dominant polycystic kidney disease: Design and baseline characteristics of participants
por: Nowak, Kristen L., et al.
Publicado: (2020)

Sex Differences in Cardiovascular and All-Cause Mortality in Adults with and without CKD: NHANES 1999–2018
por: Oh, Ester S., et al.
Publicado: (2023)

Deoxycholic Acid and Risks of Cardiovascular Events, ESKD, and Mortality in CKD: The CRIC Study
por: Frazier, Rebecca, et al.
Publicado: (2021)

The association between uric acid levels and renal function of CKD patients with hyperlipidemia: a sub-analysis of the ASUCA trial
por: Kuwabara, Yoshihiro, et al.
Publicado: (2019)

Corrigendum: Impact of Serum Uric Acid Lowering and Contemporary Uric Acid-Lowering Therapies on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis
por: Ying, Hangying, et al.
Publicado: (2021)

Early Diabetic Nephropathy: A complication of reduced insulin sensitivity in type 1 diabetes
por: Bjornstad, Petter, et al.
Publicado: (2013)

25-vitamin D, 1,25-vitamin D, parathyroid hormone, fibroblast growth factor-23 and cognitive function in men with advanced CKD: a veteran population
por: Jovanovich, Anna J., et al.
Publicado: (2014)

Nicotinamide Riboside Supplementation for Treating Elevated Systolic Blood Pressure and Arterial Stiffness in Midlife and Older Adults
por: Freeberg, Kaitlin A., et al.
Publicado: (2022)

Electrochemical analysis of uric acid excretion to the intestinal lumen: Effect of serum uric acid-lowering drugs and 5/6 nephrectomy on intestinal uric acid levels
por: Fujita, Kyoko, et al.
Publicado: (2019)

Effect of dapagliflozin on kidney and cardiovascular outcomes by baseline KDIGO risk categories: a post hoc analysis of the DAPA-CKD trial
por: Waijer, Simke W., et al.
Publicado: (2022)

Treatment satisfaction with molidustat in CKD-related anemia in non-dialysis patients: a post-hoc analysis of two clinical trials
por: Yamamoto, Hiroyasu, et al.
Publicado: (2023)

Friend or Foe? An Unrecognized Role of Uric Acid in Cancer Development and the Potential Anticancer Effects of Uric Acid-lowering Drugs
por: Mi, Shuyi, et al.
Publicado: (2020)

Serum uric acid and target organ damage in essential hypertension
por: Ofori, Sandra N, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_d826i9uifp7gvgapj790blu3mj